Drug-eluting / bioactive coating

A drug-eluting coating is a surface layer engineered to release a bioactive agent locally into the perielectrode tissue to blunt the foreign-body response. The most common payload is the corticosteroid dexamethasone, which suppresses microglial activation and astrogliosis; others include anti-inflammatory and anti-fibrotic molecules, neurite-promoting factors, and neural-adhesion peptides that encourage neurons to remain close to the site.

By dampening inflammation in the critical early window after insertion, such coatings can reduce encapsulation thickness and preserve nearby neurons, improving early signal quality. Their fundamental limitation is a finite drug reservoir: elution follows a diffusion-limited profile that tapers over days to weeks, so a coating that protects the acute phase cannot by itself sustain an effect across a multi-year implant, motivating refillable, hydrogel, or slow-release reservoir designs.